The treatment of Parkinson's disease with grafts of fetal ventral mesencephalic tissue has shown some success, but can result in graft-induced dyskinesias (GIDs). Recently in Science Translational Medicine, Politis et al. (2010) demonstrate that GIDs may originate from serotoninergic neurons that are cografted in these transplants
The observation that neural grafts can induce dyskinesias has severely hindered the development of a...
SummaryTransplantation of DA neurons is actively pursued as a restorative therapy in Parkinson’s dis...
Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (P...
The treatment of Parkinson's disease with grafts of fetal ventral mesencephalic tissue has shown som...
The development of neural transplantation as a treatment for Parkinson’s disease has been compromise...
Graft-induced dyskinesias are a serious complication after neural transplantation in Parkinson's dis...
Clinical trials evaluating transplantation of fetal tissue for the treatment of Parkinson's disease ...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Both increased and decreased dyskinesias have been reported from open label clinical trials of trans...
The transplantation of dopaminergic cells for the treatment of symptoms of Parkinson’s diseas...
Severe dyskinesias during the 'off' phases (periods of increased Parkinson's disease (PD) disability...
Troublesome involuntary movements in the absence of dopaminergic medication, so-called off-medicatio...
Dyskinesia seen in the off-state, referred as graft-induced dyskinesia (GID), has emerged as a serio...
One of the major symptoms of the neurodegenerative condition Parkinson's disease (PD) is a slowness ...
The observation that neural grafts can induce dyskinesias has severely hindered the development of a...
SummaryTransplantation of DA neurons is actively pursued as a restorative therapy in Parkinson’s dis...
Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (P...
The treatment of Parkinson's disease with grafts of fetal ventral mesencephalic tissue has shown som...
The development of neural transplantation as a treatment for Parkinson’s disease has been compromise...
Graft-induced dyskinesias are a serious complication after neural transplantation in Parkinson's dis...
Clinical trials evaluating transplantation of fetal tissue for the treatment of Parkinson's disease ...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Both increased and decreased dyskinesias have been reported from open label clinical trials of trans...
The transplantation of dopaminergic cells for the treatment of symptoms of Parkinson’s diseas...
Severe dyskinesias during the 'off' phases (periods of increased Parkinson's disease (PD) disability...
Troublesome involuntary movements in the absence of dopaminergic medication, so-called off-medicatio...
Dyskinesia seen in the off-state, referred as graft-induced dyskinesia (GID), has emerged as a serio...
One of the major symptoms of the neurodegenerative condition Parkinson's disease (PD) is a slowness ...
The observation that neural grafts can induce dyskinesias has severely hindered the development of a...
SummaryTransplantation of DA neurons is actively pursued as a restorative therapy in Parkinson’s dis...
Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (P...
DOI
Add to ORKG